ATXN3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.672000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.884400E-01
Normal-vs-Stage2
6.793400E-01
Normal-vs-Stage3
8.874000E-01
Normal-vs-Stage4
3.348800E-01
Stage1-vs-Stage2
1.832610E-01
Stage1-vs-Stage3
6.073200E-01
Stage1-vs-Stage4
2.515200E-01
Stage2-vs-Stage3
5.318200E-01
Stage2-vs-Stage4
4.231600E-01
Stage3-vs-Stage4
2.982600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.480400E-01
Normal-vs-AfricanAmerican
7.308400E-01
Normal-vs-Asian
9.036600E-01
Caucasian-vs-AfricanAmerican
4.175600E-01
Caucasian-vs-Asian
3.914000E-01
AfricanAmerican-vs-Asian
9.011400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.083600E-01
Normal-vs-Female
8.465000E-01
Male-vs-Female
4.949800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.843800E-01
Normal-vs-Age(41-60Yrs)
4.599000E-01
Normal-vs-Age(61-80Yrs)
9.612200E-01
Normal-vs-Age(81-100Yrs)
9.772000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.496800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.136600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.687600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.998700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.628030E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.558800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.723200E-01
Normal-vs-Daily Drinker
9.419200E-01
Normal-vs-Weekly Drinker
9.609600E-01
Normal-vs-Occasional Drinker
3.763200E-01
Normal-vs-Social Drinker
9.818200E-01
Non Drinker-vs-Daily Drinker
8.115400E-01
Non Drinker-vs-Weekly Drinker
8.784200E-01
Non Drinker-vs-Occasional Drinker
6.582100E-02
Non Drinker-vs-Social Drinker
9.149200E-01
Daily Drinker-vs-Weekly Drinker
9.466800E-01
Daily Drinker-vs-Occasional Drinker
2.024200E-01
Daily Drinker-vs-Social Drinker
9.120400E-01
Weekly Drinker-vs-Occasional Drinker
1.592820E-01
Weekly Drinker-vs-Social Drinker
9.641400E-01
Occasional Drinker-vs-Social Drinker
1.315830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.694200E-01
Normal-vs-Grade 2
2.704300E-02
Normal-vs-Grade 3
4.724000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.002190E-04
Grade 1-vs-Grade 3
7.5264999999991E-05
Grade 1-vs-Grade 4
2.694200E-01
Grade 2-vs-Grade 3
1.357400E-01
Grade 2-vs-Grade 4
2.704300E-02
Grade 3-vs-Grade 4
4.724000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.184000E-01
Normal-vs-NonDiabetic
8.251800E-01
Diabetic-vs-NonDiabetic
6.340800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.202200E-01
Normal-vs-NoPancreatitis
7.608800E-01
Pancreatitis-vs-NoPancreatitis
4.276000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.582800E-01
Normal-vs-N1
6.299800E-01
N0-vs-N1
6.914100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.354400E-01
Normal-vs-TP53-NonMutant
4.099800E-01
TP53-Mutant-vs-TP53-NonMutant
3.635099999999E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
